KIN - Kindred Biosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2020)Next Qtr. (Jun 2020)Current Year (2020)Next Year (2021)
No. of Analysts8888
Avg. Estimate-0.430.03-1.1-1.04
Low Estimate-0.45-0.43-1.69-1.6
High Estimate-0.390.73-0.190.71
Year Ago EPS-0.42-0.37-1.59-1.1
Revenue EstimateCurrent Qtr. (Mar 2020)Next Qtr. (Jun 2020)Current Year (2020)Next Year (2021)
No. of Analysts7788
Avg. Estimate1.59M12.86M15.31M21.06M
Low Estimate1.4M300k2.8M1.2M
High Estimate1.8M44.6M48.1M79.71M
Year Ago Sales1.9MN/A4.26M15.31M
Sales Growth (year/est)-16.30%N/A259.70%37.60%
Earnings History2019-03-302019-06-292019-09-292019-12-30
EPS Est.-0.41-0.38-0.37-0.36
EPS Actual-0.42-0.37-0.39-0.4
Difference-0.010.01-0.02-0.04
Surprise %-2.40%2.60%-5.40%-11.10%
EPS TrendCurrent Qtr. (Mar 2020)Next Qtr. (Jun 2020)Current Year (2020)Next Year (2021)
Current Estimate-0.430.03-1.1-1.04
7 Days Ago-0.430.03-1.1-1.04
30 Days Ago-0.430.03-1.1-1.04
60 Days Ago-0.35-0.32-1.32-0.96
90 Days Ago-0.35-0.32-1.32-0.96
EPS RevisionsCurrent Qtr. (Mar 2020)Next Qtr. (Jun 2020)Current Year (2020)Next Year (2021)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesKINIndustrySectorS&P 500
Current Qtr.-2.40%N/AN/A-0.34
Next Qtr.108.10%N/AN/A-0.12
Current Year30.80%N/AN/A-0.18
Next Year5.50%N/AN/A0.26
Next 5 Years (per annum)40.00%N/AN/A0.04
Past 5 Years (per annum)N/AN/AN/AN/A